About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

OMICS: A Journal of Integrative Biology

Editor-in-Chief: Vural Özdemir, MD, PhD, DABCP

ISSN: 1536-2310 • Published Monthly • Online ISSN: 1557-8100

Current Volume: 18

Latest Impact Factor* is 2.730

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    OMICS:  A Journal of Integrative Biology seeks high quality, original-research papers dealing with all aspects of integrative biology, diverse “OMICS-es,” such as genomics, transcriptomics, proteomics, metabolomics, pharmacogenomics, physiomics, etc., and their integration, data analysis, and modeling. OMICS:  A Journal of Integrative Biology is an interdisciplinary forum of postgenomic biology and medicine for networking researchers from various fields, focusing on applications to study biological problems and foster new biological knowledge. Manuscripts dealing with the ethical, legal, and social implications of the different scientific and technological aspects of integrative biology are also solicited. The Journal will also publish reviews and minireviews pertinent to integrative biology and OMICS-es, as well as meeting abstracts, summaries, commentaries, and book reviews.

    Manuscripts submitted to OMICS must not be under consideration elsewhere or have been previously published.

    All new manuscripts must be submitted online at:


    Preparation of Manuscript

    NOTE: All submitted manuscripts will be processed through plagiarism detection software.  Plagiarized manuscripts will be rejected immediately. 

    Please prepare all text manuscripts in Microsoft Word double-spaced in at least 12 pt type.  Leave ample margins on both sides, top and bottom. 

    The first page should include the article title, all contributing authors, and the full mailing address and contact information (telephone, fax, and e-mail) for EACH author listed on the manuscript.  Please also indicate the corresponding author and include key words.

    Manuscripts should be organized with: (1) a title page containing the full title of the paper with the names, affiliations, and full contact information of all authors; (2) an Abstract of 200 words with key words underlined (reference citations are not permitted in the Abstract); (3) a concise, clearly worded and constructed Introduction; (4) Materials and Methods containing sufficient detail to allow for reproduction; * (5) a Results section; (6) a Discussion involving interpretation of the results including their relationship to the existing body of knowledge in the field; (7) Conclusions; (8) Acknowledgments; (9) Disclosures and (10) References. ** Standard abbreviations as defined by the Journal of Biological Chemistry are acceptable; other necessary abbreviations should be listed as a footnote to appear on the first page of the published article. Authors should review the style and clarity of their manuscripts with colleagues before submission. Please follow the protocol described herein to avoid delay in publication. Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage. The Editor welcomes suggestions concerning potential reviewers.  Please do not leave space between paragraphs within a section. 

    Supplementary material can be submitted.

    *OMICS supports the use of minimum reporting standards as guidance on the level of detail that should accompany a publication; either in the main text, or as supplementary information.  We therefore recommend that allow authors and reviewers refer to the MIBBI Portal http://mibbi.org/index.php/MIBBI_Portal and consult any appropriate guidance to be found there.

    **Please be extremely careful with the Reference section and precisely follow our sample References (see below).  This is by far a major source of errors in the submitted manuscripts.

    Tables and Illustrations

    Prepare each table with its title in a separate file. Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.  Tables may be prepared in Microsoft Word but presented in the Microsoft Word text document AFTER the references.  Each table must be prepared as a separate page. All illustrations should be numbered.A legend should be supplied for each illustration and all legends numbered consecutively and double-spaced in a separate file. Figures should be numbered in the order cited in the text.  Images should not show the name of a manufacturer. Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction
    Please follow these guidelines for submitting figures:

    • Do NOT embed art files into a Word or PDF document.
    • Line illustrations should be submitted at  900 dpi.
    • Halftones and color should be submitted at a minimum of 300 dpi.
    • Each figure must be saved as a separate file.  Do not embed figures in the text manuscript.
    • Save as either TIFF or EPS files.
    • Color art must be saved as CYMK - not RGB.
    • Black and White art must be submitted as grayscale – not RGB.
    • PowerPoint or Excel files cannot be uploaded.

    Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc.  Authors who do not follow these guidelines may have their submission returned to them without being reviewed.


    Converting Word or Excel files:
      Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

    • All files should be scanned at 100% size.
    • 300 dpi
    • Final color mode: cmyk
    • save file as: .tif or .eps
    If you need directions on how to convert a Power Point slide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf

    Color Artwork:  Color images are posted online for free.

    Disclosure Statement
    Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."


    Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your paper.  Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.



    References should begin on a separate page after the text and before the tables.  Cite the references in the text by name and date. In the reference list, list the references alphabetically in the following style. The first 6 authors must be listed; thereafter use “et al.”

      Journal citation:
      Davidson BL., Allen ED, Kozarsky KF, Wilson JM, and Roessler BJ (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genetics 3, 219–223.

      Book citation:
      Sambrook J, Fritsch EF, and Maniatis T (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York).


          When dates from an unpublished source are given, supply the researcher’s name. If work is in press, give the journal in which it is to be published or the name of the publisher. Abbreviations of journal names should follow the style of Medline.


    The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure, should read, “reprinted by permission from Jones et al.” and list the appropriate reference. All permissions listings must be shown in the manuscript; they cannot be entered on proofs.


    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

    OMICS:  A Journal of Integrative Biology is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740-2100; Fax: (914) 740-2101  www.liebertpub.com 

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Genetic Engineering & Biotechnology News

    Genetic Engineering & Biotechnology News

    The mostly widely-read publication covering tools, techniques, and technologies in the biotechnology industry.

    ASSAY and Drug Development Technologies

    ASSAY and Drug Development Technologies

    This authoritative, rapidly peer-reviewed journal features original articles, application-oriented technology reviews, and reports in methodology and technology application.

    Journal of Computational Biology

    Journal of Computational Biology

    The leading peer-reviewed journal in the analysis, management, and visualization of cellular information at the molecular level, offering articles on novel, cutting-edge methods in computational biology and bioinformatics.

    Cellular Reprogramming

    Cellular Reprogramming

    Cutting-edge techniques and the latest high-quality research on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms.

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

Browse All Publications »